Dr Fang Liu is an Associate Professor in Research at the University of Hertfordshire. She obtained her PhD in Pharmaceutics in 2008 from the School of Pharmacy, University of London, before undertaking a Post-Doctoral research position in the same institution. Her invention during this time, the DuoCoat® - an advanced oral drug delivery technology, has been applied to the ASACOL™ 1600 mg (mesalazine, based on OPTICORE™) product by Tillotts Pharma along side the Phloral™ technology. 

 

In November 2009, Dr Liu joined the University of Hertfordshire as a Lecturer in Clinical Pharmaceutics. Her research interests focus on developing patient-centric medicines for children and older adults. She is a co-chair of the Age-Related Medicines Focus Group in Academy of Pharmaceutical Sciences of Great Britain (APSGB), and is involved in the work of European Paediatric Formulation Initiative (EuPFI) and the Patient Centric Medicine (PaCeMe) initiative. She has published her work in over 25 peer reviewed journal articles and is the Founder and Executive Director of Fluid Pharma Ltd.